Morning Overview on MSN
Long-read RNA sequencing tool boosts rare-disease diagnoses missed by DNA tests
For years, two siblings with the distinctive facial features of Treacher Collins syndrome had no genetic explanation for their condition. Exome sequencing came back clean. Chromosomal microarray found ...
The honorees are scheduled to deliver lectures during this year’s meeting in San Diego, CA, which runs from April 17-22.
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other ...
A clinician-led approach boosts genetic testing among relatives of people with newly detected pathogenic variants — and could help close a gap in hereditary cancer prevention.
Everyday Health on MSN
Genetic Testing and ATTR-CM: Everything You Need to Know
Learn why genetic testing is vital for ATTR-CM diagnosis, how it identifies hereditary risks for family members, and the ...
A virtual tool can facilitate cascade genetic testing for relatives of people with cancer who have pathogenic variants, ...
Two New Jersey genetic-testing companies are being sued by IVF patients who claim they were misled about the health of ...
Hackettstown-based Genomic Prediction and Livingston-based Cooper Genomics face federal class action lawsuits alleging false ...
WYFF News 4 on MSN
New upstate medical test could save children's lives
A new genetic test formulated in the Upstate could save countless children's lives.
MethylScan is a low-cost blood test that detects cancers and organ diseases by analyzing DNA methylation, improving early diagnosis, and identifying disease origin.
SALT LAKE CITY, April 16, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announced that it will share six abstracts, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results